Terms: = Leukemia AND POU2AF1, OBF1, 5450, ENSG00000110777, BOB1, OCAB, Q16633, OBF-1
17 results:
1. Validation of genes for H-ARS severity prediction in leukemia patients - interspecies comparison, challenges, and promises.
Schwanke D; Valente M; Ostheim P; Schüle S; Bobyk L; Drouet M; Riccobono D; Magné N; Daguenet E; Stewart SJ; Muhtadi R; Port M; Abend M
Int J Radiat Biol; 2024; 100(4):527-540. PubMed ID: 38227483
[TBL] [Abstract] [Full Text] [Related]
2. [Regulation of microRNA-126 on the polarization of human macrophages stimulated by
Li JJ; Liu Y; Song LT; Li CY; Jiang SY
Zhonghua Kou Qiang Yi Xue Za Zhi; 2022 Apr; 57(4):390-396. PubMed ID: 35368165
[No Abstract] [Full Text] [Related]
3. T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion.
Morton LT; Wachsmann TLA; Meeuwsen MH; Wouters AK; Remst DFG; van Loenen MM; Falkenburg JHF; Heemskerk MHM
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35288464
[TBL] [Abstract] [Full Text] [Related]
4. A B-cell developmental gene regulatory network is activated in infant AML.
Bolouri H; Ries R; Pardo L; Hylkema T; Zhou W; Smith JL; Leonti A; Loken M; Farrar JE; Triche TJ; Meshinchi S
PLoS One; 2021; 16(11):e0259197. PubMed ID: 34793513
[TBL] [Abstract] [Full Text] [Related]
5. Lymphocyte-depleted classic Hodgkin lymphoma with primary extranodal disease: Two cases that highlight the combination of immunodeficiency and immune escape in the pathogenesis.
Tsuyuki Y; Kohno K; Inagaki Y; Sakai Y; Kosugi H; Takahashi E; Suzuki Y; Shimada S; Kato S; Takahara T; Satou A; Shimoyama Y; Nakamura S; Asano N; Sakakibara A
J Clin Exp Hematop; 2021; 61(3):173-179. PubMed ID: 34511545
[TBL] [Abstract] [Full Text] [Related]
6. Impact of Inter-Individual Variance in the Expression of a Radiation-Responsive Gene Panel Used for Triage.
Agbenyegah S; Abend M; Atkinson MJ; Combs SE; Trott KR; Port M; Majewski M
Radiat Res; 2018 Sep; 190(3):226-235. PubMed ID: 29923790
[TBL] [Abstract] [Full Text] [Related]
7. Validating Baboon Ex Vivo and In Vivo Radiation-Related Gene Expression with Corresponding Human Data.
Port M; Majewski M; Herodin F; Valente M; Drouet M; Forcheron F; Tichy A; Sirak I; Zavrelova A; Malkova A; Becker BV; Veit DA; Waldeck S; Badie C; O'Brien G; Christiansen H; Wichmann J; Eder M; Beutel G; Vachelova J; Doucha-Senf S; Abend M
Radiat Res; 2018 Apr; 189(4):389-398. PubMed ID: 29373091
[TBL] [Abstract] [Full Text] [Related]
8. Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients.
Ou R; Huang J; Shen H; Liu Z; Zhu Y; Zhong Q; Zheng L; Yao M; She Y; Zhou S; Chen R; Li C; Zhang Q; Liu S
Leuk Res; 2017 Nov; 62():40-50. PubMed ID: 28982058
[TBL] [Abstract] [Full Text] [Related]
9. Trends and Patterns of Disparities in Cancer Mortality Among US Counties, 1980-2014.
Mokdad AH; Dwyer-Lindgren L; Fitzmaurice C; Stubbs RW; Bertozzi-Villa A; Morozoff C; Charara R; Allen C; Naghavi M; Murray CJ
JAMA; 2017 Jan; 317(4):388-406. PubMed ID: 28118455
[TBL] [Abstract] [Full Text] [Related]
10. TCR-based therapy for multiple myeloma and other B-cell malignancies targeting intracellular transcription factor bob1.
Jahn L; Hombrink P; Hagedoorn RS; Kester MG; van der Steen DM; Rodriguez T; Pentcheva-Hoang T; de Ru AH; Schoonakker MP; Meeuwsen MH; Griffioen M; van Veelen PA; Falkenburg JH; Heemskerk MH
Blood; 2017 Mar; 129(10):1284-1295. PubMed ID: 28053195
[TBL] [Abstract] [Full Text] [Related]
11. Very late relapse of PTLD 10 yr after allogeneic HSCT and nine yr after stopping immunosuppressive therapy.
Helgestad J; Rosthøj S; Pedersen MH; Johansen P; Iyer V; Østergaard E; Heilmann C
Pediatr Transplant; 2014 Feb; 18(1):E35-9. PubMed ID: 24168387
[TBL] [Abstract] [Full Text] [Related]
12. [Variant Philadelphia chromosome identified by interphase fluorescence in situ hybridization (FISH) without evidence on G-banded karyotyping and metaphase FISH].
Kim MK; Mun YC; Seong CM; Chung WS; Huh J
Korean J Lab Med; 2010 Dec; 30(6):711-7. PubMed ID: 21157160
[TBL] [Abstract] [Full Text] [Related]
13. Expression of B cell-specific activator protein/PAX5 in acute myeloid leukemia with t(8;21)(q22;q22).
Valbuena JR; Medeiros LJ; Rassidakis GZ; Hao S; Wu CD; Chen L; Lin P
Am J Clin Pathol; 2006 Aug; 126(2):235-40. PubMed ID: 16891199
[TBL] [Abstract] [Full Text] [Related]
14. Identification of a potential role for pou2af1 and BTG4 in the deletion of 11q23 in chronic lymphocytic leukemia.
Auer RL; Starczynski J; McElwaine S; Bertoni F; Newland AC; Fegan CD; Cotter FE
Genes Chromosomes Cancer; 2005 May; 43(1):1-10. PubMed ID: 15672409
[TBL] [Abstract] [Full Text] [Related]
15. Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease.
Yuille MA; Galiegue-Zouitina S; Hiorns LR; Jadayel D; De Schouwer PJ; Catovsky D; Dyer MJ; Kerckaert JP
Leukemia; 1996 Sep; 10(9):1492-6. PubMed ID: 8751468
[TBL] [Abstract] [Full Text] [Related]
16. The B cell transcriptional coactivator bob1/obf1 gene fuses to the LAZ3/BCL6 gene by t(3;11)(q27;q23.1) chromosomal translocation in a B cell leukemia line (Karpas 231).
Galiègue Zouitina S; Quief S; Hildebrand MP; Denis C; Lecocq G; Collyn-d'Hooghe M; Bastard C; Yuille M; Dyer MJ; Kerckaert JP
Leukemia; 1996 Apr; 10(4):579-87. PubMed ID: 8618432
[TBL] [Abstract] [Full Text] [Related]
17. Fusion of the LAZ3/BCL6 and bob1/obf1 genes by t(3; 11) (q27; q23) chromosomal translocation.
Galiègue-Zouitina S; Quief S; Hildebrand MP; Denis C; Lecocq G; Collyn-d'Hooghe M; Bastard C; Yuille M; Dyer MJ; Kerckaert JP
C R Acad Sci III; 1995 Nov; 318(11):1125-31. PubMed ID: 8574789
[TBL] [Abstract] [Full Text] [Related]
